Reimbursed treatment, regulated in the national frame contract.
The investigation is an analysis of the main elements, included in the reimbursement system for the drug insurance. The aim is directly dependent on the valuation for the adequate service of the arise health needs of the citizens that are obligatory insured. The used methods are connected with an analysis of the regulations and of the statistical information. As result of the investigation are characterized the seize of the disease and of the drug nomenclature with a forecast reimburse therapy. The provide valuation of the objective state of the system shows that the criteria and rules are not clear and precise in respect of: the include of the drugs in the positive list, the determination of the level of reimbursement, the selection of the disease with the reimbursement treatment and especially of those with totally reimbursed therapy. The investigation shows that the accepted principles in this area are appropriate with the modern concepts and tendencies, but for their real realization are necessary additional attempts for overcoming of the negatives in the process of developments through adequate administrative decisions and approaches.